{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:42:30Z","timestamp":1758400950165},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1007\/s11936-000-0038-6","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T12:39:22Z","timestamp":1180874362000},"page":"431-438","source":"Crossref","is-referenced-by-count":25,"title":["Restrictive cardiomyopathy"],"prefix":"10.1007","volume":"2","author":[{"given":"Gregory","family":"Artz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"MG Felker","year":"2000","unstructured":"Felker MG, Thompson RE, Hare J, et al.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000, 342:1077\u20131084. This article supports the importance of diagnosing the specific type of cardiomyopathy a patient has because of the significant differences in survival.","journal-title":"N Engl J Med"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","volume":"336","author":"SS Kushwaha","year":"1997","unstructured":"Kushwaha SS, Fallon JT, Fuster V: Restrictive cardiomyopathy. N Engl J Med 1997, 336:267\u2013276. Excellent overview of the causes and treatment of RCM.","journal-title":"N Engl J Med"},{"key":"38_CR3","first-page":"1404","volume-title":"Heart Disease","author":"J Wynne","year":"1996","unstructured":"Wynne J, Braunwald E: The cardiomyopathies and myocarditides: toxic, chemical and physical damage to the heart. In Heart Disease, edn 5. Edited by Braunwald E. Philadelphia: W.B. Saunders; 1996:1404\u20131463.","edition":"edn 5"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","volume":"104","author":"A Pollak","year":"1993","unstructured":"Pollak A, Falk RH: Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 1993, 104:618\u2013620.","journal-title":"Chest"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00001573-199405000-00013","volume":"9","author":"N Spyrou","year":"1994","unstructured":"Spyrou N, Foale R: Restrictive cardiomyopathies. Curr Opin Cardiol 1994, 9:344\u2013348.","journal-title":"Curr Opin Cardiol"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"MH Kulke","year":"1999","unstructured":"Kulke MH, Mayer RJ: Carcinoid tumors. N Engl J Med 1999, 340:858\u2013868.","journal-title":"N Engl J Med"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","volume":"338","author":"ME Rothenberg","year":"1998","unstructured":"Rothenberg ME: Eosinophilia. N Engl J Med 1998, 338:1592\u20131600. Comprehensive review of the pathobiology of the eosinophil in health and disease.","journal-title":"N Engl J Med"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9149(98)00377-4","volume":"82","author":"Y Yazaki","year":"1998","unstructured":"Yazaki Y, Isobe M, Hiramitsu S, et al.: Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998, 82:537\u2013540.","journal-title":"Am J Cardiol"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.314.7077.320","volume":"314","author":"DN Mitchell","year":"1997","unstructured":"Mitchell DN, DuBois RM, Oldershaw PJ: Cardiac sarcoidosis. BMJ 1997, 314:320\u2013321. Short but good article outlining cardiac sarcoid and its therapy.","journal-title":"BMJ"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","volume":"100","author":"M Skinner","year":"1996","unstructured":"Skinner M, Anderson J, Simms R, et al.: Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996, 100:290\u2013298.","journal-title":"Am J Med"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","volume":"100","author":"V Mathew","year":"1996","unstructured":"Mathew V, Olson L, Gertz M, et al.: Symptomatic conduction system disease in cardiac amyloidosis. Am J Med 1996, 100:290\u2013298.","journal-title":"Am J Med"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-125-6-199609150-00009","volume":"125","author":"S Dubrey","year":"1996","unstructured":"Dubrey S, Mendes L, Skinner M, et al.: Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med 1996, 125:481\u2013484.","journal-title":"Ann Intern Med"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0002-9343(98)00037-0","volume":"104","author":"VS Rajkumar","year":"1998","unstructured":"Rajkumar VS, Gertz M, Kyle R: Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998, 104:232\u2013237.","journal-title":"Am J Med"},{"key":"38_CR14","first-page":"74","volume":"26","author":"R Kyle","year":"1999","unstructured":"Kyle R: High-dose therapy in multiple myeloma and primary amyloidosis: an overview. Semin Oncol 1999, 26:74\u201383. Classic article that outlined novel approach to the treatment of primary amyloidosis.","journal-title":"Semin Oncol"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/01.CIR.101.21.2490","volume":"101","author":"N Ammash","year":"2000","unstructured":"Ammash N, Seward J, Bailey K, et al.: Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 2000, 101:2490\u20132496. This article provides an excellent profile of the clinical features of idiopathic RCM.","journal-title":"Circulation"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0008-6363(96)88509-9","volume":"30","author":"C Kartha","year":"1995","unstructured":"Kartha C: Endomyocardial fibrosis: a case for the tropical doctor. Cardiovasc Res 1995, 30:635\u2013643. A good, detailed article about a disease rarely seen in the western world.","journal-title":"Cardiovasc Res"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bmj.309.6962.1135","volume":"309","author":"R Hall","year":"1994","unstructured":"Hall R, Hawkins PN: Cardiac transplantation for AL amyloidosis. BMJ 1994, 309:1135\u20131137.","journal-title":"BMJ"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9149(97)00806-0","volume":"79","author":"F Pelosi","year":"1997","unstructured":"Pelosi F, Capehart J, Roberts W: Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis. Am J Cardiol 1997, 79:532\u2013535.","journal-title":"Am J Cardiol"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9149(99)80214-8","volume":"76","author":"S Dubrey","year":"1995","unstructured":"Dubrey S, Simms R, Skinner M, et al.: Recurrence of primary (AL) amyloidosis in a transplant heart with four-years survival. Am J Cardiol 1995, 76:739\u2013741.","journal-title":"Am J Cardiol"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7326\/0003-4819-122-7-199504010-00005","volume":"122","author":"M VanBuren","year":"1995","unstructured":"VanBuren M, Hene R, Verdonck L, et al.: Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis. Ann Intern Med 1995, 122:508\u2013510.","journal-title":"Ann Intern Med"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-000-0038-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0038-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:52:25Z","timestamp":1559436745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-000-0038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11936-000-0038-6","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}